Sedana Medical AB (publ) (SEDANA.ST)
SEK 16.0
(0.38%)
SEK 16.0
(0.38%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -51.67 Million SEK | -21.85% |
| 2022 | -64.87 Million SEK | -11.36% |
| 2021 | -49.1 Million SEK | -364.04% |
| 2020 | -17.22 Million SEK | 17.04% |
| 2019 | -13.07 Million SEK | -1232.05% |
| 2018 | -2.87 Million SEK | -6733.6% |
| 2017 | -12.5 Thousand SEK | -100.41% |
| 2016 | 1.6 Million SEK | 1761.35% |
| 2015 | 163 Thousand SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -963 Thousand SEK | 64.37% |
| 2024 Q2 | -11.72 Million SEK | -263.36% |
| 2024 Q3 | -9 Million SEK | 23.16% |
| 2023 Q2 | 8.5 Million SEK | 190.28% |
| 2023 Q1 | -9.41 Million SEK | 36.61% |
| 2023 Q4 | -7.66 Million SEK | -624.76% |
| 2023 Q3 | -1.05 Million SEK | -112.44% |
| 2023 FY | - SEK | -21.85% |
| 2022 Q1 | -12.98 Million SEK | -24.32% |
| 2022 Q2 | -4.57 Million SEK | 64.75% |
| 2022 FY | - SEK | -11.36% |
| 2022 Q3 | -1.27 Million SEK | 72.2% |
| 2022 Q4 | -14.85 Million SEK | -1066.93% |
| 2021 Q2 | -14.28 Million SEK | -114.56% |
| 2021 FY | - SEK | -364.04% |
| 2021 Q1 | -6.65 Million SEK | -6.0% |
| 2021 Q4 | -10.44 Million SEK | 13.7% |
| 2021 Q3 | -12.1 Million SEK | 15.23% |
| 2020 Q4 | -6.28 Million SEK | 9.63% |
| 2020 FY | - SEK | 17.04% |
| 2020 Q3 | -6.94 Million SEK | -12040.68% |
| 2020 Q2 | 58.19 Thousand SEK | -98.44% |
| 2020 Q1 | 3.73 Million SEK | 158.68% |
| 2019 Q3 | -3.08 Million SEK | -67.28% |
| 2019 Q2 | -1.84 Million SEK | -141.21% |
| 2019 Q4 | -6.36 Million SEK | -106.31% |
| 2019 FY | - SEK | -1232.05% |
| 2019 Q1 | -764.09 Thousand SEK | 81.8% |
| 2018 Q1 | 1.31 Million SEK | 186.61% |
| 2018 Q2 | 1.06 Million SEK | -18.99% |
| 2018 Q3 | 956.19 Thousand SEK | -10.54% |
| 2018 Q4 | -4.19 Million SEK | -539.11% |
| 2018 FY | - SEK | -6733.6% |
| 2017 Q2 | 1.34 Million SEK | 64.25% |
| 2017 Q3 | -646.95 Thousand SEK | -148.03% |
| 2017 Q4 | -1.52 Million SEK | -135.47% |
| 2017 Q1 | 820 Thousand SEK | -36.17% |
| 2017 FY | - SEK | -100.41% |
| 2016 Q1 | 1.44 Million SEK | 0.0% |
| 2016 FY | - SEK | 1761.35% |
| 2016 Q4 | 1.28 Million SEK | 114.45% |
| 2016 Q2 | -291.85 Thousand SEK | -120.16% |
| 2016 Q3 | 599.01 Thousand SEK | 305.25% |
| 2015 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acarix AB (publ) | -77.12 Million SEK | 32.997% |
| ADDvise Group AB (publ) | 411.9 Million SEK | 112.545% |
| ADDvise Group AB (publ) | 411.9 Million SEK | 112.545% |
| Arcoma AB | 6.24 Million SEK | 927.049% |
| Bactiguard Holding AB (publ) | -89.98 Million SEK | 42.573% |
| BICO Group AB (publ) | 322.3 Million SEK | 116.033% |
| Boule Diagnostics AB (publ) | 65.97 Million SEK | 178.319% |
| CellaVision AB (publ) | 207.24 Million SEK | 124.934% |
| Clinical Laserthermia Systems AB (publ) | -68.4 Million SEK | 24.46% |
| Chordate Medical Holding AB (publ) | -27.94 Million SEK | -84.926% |
| C-Rad AB (publ) | 48.9 Million SEK | 205.664% |
| Duearity AB (publ) | -24.77 Million SEK | -108.539% |
| Dignitana AB (publ) | -264 Thousand SEK | -19473.484% |
| Episurf Medical AB (publ) | -87.7 Million SEK | 41.079% |
| Getinge AB (publ) | 5.92 Billion SEK | 100.872% |
| Scandinavian Real Heart AB (Publ) | -67.25 Million SEK | 23.161% |
| Iconovo AB (publ) | -35.33 Million SEK | -46.238% |
| Integrum AB (publ) | 8.76 Million SEK | 689.783% |
| Luxbright AB (publ) | -23.86 Million SEK | -116.511% |
| Mentice AB (publ) | 28.87 Million SEK | 278.97% |
| OssDsign AB (publ) | -122.02 Million SEK | 57.652% |
| Paxman AB (publ) | 31.22 Million SEK | 265.468% |
| Promimic AB (publ) | -3.68 Million SEK | -1302.661% |
| Qlife Holding AB (publ) | -150.5 Million SEK | 65.666% |
| SciBase Holding AB (publ) | -51.82 Million SEK | 0.299% |
| ScandiDos AB (publ) | -13.35 Million SEK | -286.897% |
| Sectra AB (publ) | 615.06 Million SEK | 108.401% |
| Senzime AB (publ) | -118.82 Million SEK | 56.512% |
| SpectraCure AB (publ) | -20.96 Million SEK | -146.43% |
| Stille AB | 56.04 Million SEK | 192.207% |
| Vitrolife AB (publ) | -3.18 Billion SEK | 98.378% |
| Xvivo Perfusion AB (publ) | 126.57 Million SEK | 140.825% |